Peptide record

TPDB47655

ACE inhibitor from wheat germ hydrolysate ACE inhibitors Antihypertensive iDPPIV standard
3 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB47655
ACE inhibitor from wheat germ hydrolysate
ACE inhibitors Antihypertensive iDPPIV
Cardiometabolic peptides
Peptipedia AHTPDB AHTpin iDPPIV
standard
No
A 3-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, and iDPPIV) peptide sequence curated from Peptipedia, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
Sequence
IVY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C20H31N3O5
ARNDCEQGHLKMFPSTW
IYV
393.48
5.94
0
0
3
-0
-2.94
2.467
226.67
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
1490
3.79
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
3 reviewed residue count
C20H31N3O5 sequence-only estimate (linear, free termini)
393.48 sequence-only estimate (linear, free termini)
5.94 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-2.94 sequence-only estimate (linear, free termini)
2.467 sequence-only estimate (linear, free termini)
393.4760 Activity
393.2256 Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
0.48 µM
Inhibitor of Angiotensin-converting enzyme (EC 3.4.15.1) (MEROPS ID: XM02-001)
ACE inhibitor
ah

Source & Reference

NA
Ueno T., Tanaka M., Matsui T., Matsumoto K.
Determination of antihypertensive small peptides, Val-Tyr and Ile-Val-Tyr, by fluorometric high-performance liquid chromatography combined with a double heart-cut column-swithcing technique. Anal. Sci., 2005, 21, 997-1000
2005
Journal

Other

3
BIOPEP database of bioactive peptides SMILES: N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)C(C)C)[C@H](CC)C InChI=1S/C20H31N3O5/c1-5-12(4)16(21)18(25)23-17(11(2)3)19(26)22-15(20(27)28)10-13-6-8-14(24)9-7-13/h6-9,11-12,15-17,24H,5,10,21H2,1-4H3,(H,22,26)(H,23,25)(H,27,28)/t12-,15-,16-,17-/m0/s1 InChiKey: QSXSHZIRKTUXNG-STECZYCISA-N
Evidence 2 Activity

Activity

IC50
Antihypertensive
0.48 µM
Inhibitor of Angiotensin-converting enzyme (EC 3.4.15.1) (MEROPS ID: XM02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Ueno T., Tanaka M., Matsui T., Matsumoto K.
Determination of antihypertensive small peptides, Val-Tyr and Ile-Val-Tyr, by fluorometric high-performance liquid chromatography combined with a double heart-cut column-swithcing technique. Anal. Sci., 2005, 21, 997-1000
2005
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
3
BIOPEP database of bioactive peptides SMILES: N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)C(C)C)[C@H](CC)C InChI=1S/C20H31N3O5/c1-5-12(4)16(21)18(25)23-17(11(2)3)19(26)22-15(20(27)28)10-13-6-8-14(24)9-7-13/h6-9,11-12,15-17,24H,5,10,21H2,1-4H3,(H,22,26)(H,23,25)(H,27,28)/t12-,15-,16-,17-/m0/s1 InChiKey: QSXSHZIRKTUXNG-STECZYCISA-N
Additional Detail Fields 1 fields
3